This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Mar 25;389(10075):1168-1170.

doi: 10.1016/S0140-6736(17)30405-1. Epub 2017 Feb 16.

Interleukin-6 inhibition for rheumatoid arthritis

Roy Fleischmann¹

Affiliations

PMID: 28215663
DOI: 10.1016/S0140-6736(17)30405-1

Comment

Interleukin-6 inhibition for rheumatoid arthritis

Roy Fleischmann. Lancet. 2017.

. 2017 Mar 25;389(10075):1168-1170.

doi: 10.1016/S0140-6736(17)30405-1. Epub 2017 Feb 16.

Author

Roy Fleischmann¹

Affiliation

¹ University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX 75231, USA. Electronic address: rfleischmann@arthdocs.com.

PMID: 28215663
DOI: 10.1016/S0140-6736(17)30405-1

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
Aletaha D, Bingham CO 3rd, Tanaka Y, Agarwal P, Kurrasch R, Tak PP, Popik S. Aletaha D, et al. Lancet. 2017 Mar 25;389(10075):1206-1217. doi: 10.1016/S0140-6736(17)30401-4. Epub 2017 Feb 16. Lancet. 2017. PMID: 28215362 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information